Charles River Laboratories International, Inc.CRL

Charles River Laboratories International, Inc. (CRL): trades by Congress and the executive branch

Every trade in Charles River Laboratories International, Inc. that a representative, a senator, the President or a senior official disclosed since 2018, newest report first. Each is read from the filer’s periodic transaction report and linked to it.

Latest report Jul 1, 2026 · Source · RSS feed

Trades disclosed
24since 2018
Members
12
Purchases / sales
12 / 12
Typical days to public
25median
Public after 45 days
3of 20 dated trades by Congress

Congress trade alerts · CRL · free

Get an email when anyone in Congress trades Charles River Laboratories International, Inc.

Each new disclosure of a trade in the stock by a representative, a senator, the President or a senior official, with the filing.

An email when a member of Congress or the executive branch files a trade in CRL, with the filing. Unsubscribe in one click.

Transactions

Every CRL trade disclosed since 2018, newest report first
MemberAssetTypeAmountTrade dateLagPublicFiling
Donald TrumpPresidentCRLCharles River Laboratories International, Inc.Sell$15K–$50KApr 27, 202665dJul 1PDF
Donald TrumpPresidentCRLCharles River Laboratories International, Inc.Buy$15K–$50KMar 25, 202650dMay 14PDF
Lori Chavez-DeRemerSecretary, Department of LaborCRLCharles River Laboratories International, Inc.Sell$1K–$15KApr 28, 2025134dSep 9PDF
Jefferson ShreveR-ININ06CRLCharles River Laboratories International, Inc.Sell$15K–$50KMay 12, 202541dJun 22PDF
Jefferson ShreveR-ININ06CRLCharles River Laboratories International, Inc.Buy$15K–$50KMay 8, 202545dJun 22PDF
Rob BresnahanR-PAPA08CRLCharles River Laboratories International, Inc.Sell$1K–$15KMay 15, 202516dMay 31PDF
Rob BresnahanR-PAPA08CRLCharles River Laboratories International, Inc.Buy$15K–$50KApr 8, 202530dMay 8PDF
Julie JohnsonD-TXTX32CRLCharles River Laboratories International, Inc. · JointBuy$1K–$15KJan 15, 202528dFeb 12PDF
Lois FrankelD-FLFL22CRLCharles River Laboratories International, Inc.Sell$1K–$15KSep 8, 202332dOct 10PDF
Lois FrankelD-FLFL22CRLCharles River Laboratories International, Inc.Buy$1K–$15KApr 25, 202324dMay 19PDF
Zoe LofgrenD-CACA19CRLCharles River Laboratories International, Inc. · SpouseSell$1K–$15KAug 25, 202219dSep 13PDF
Zoe LofgrenD-CACA19CRLCharles River Laboratories International, Inc. · SpouseBuy$1K–$15KSep 30, 20217dOct 7PDF
Eric LanderDirector, Office of Science and Technology PolicyCRLCharles River Laboratories International, Inc.Sell$250K–$500KJun 10, 202190dSep 8PDF
Donna ShalalaD-FLFL27CRLCharles River Laboratories International, Inc.Sell$1K–$15KJun 24, 2019308dApr 27PDF
Susie LeeD-NVNV03CRLCharles River Laboratories International, Inc. · JointSell$1K–$15KOct 8, 201958dDec 5PDF
Susie LeeD-NVNV03CRLCharles River Laboratories International, Inc. · JointSell$1K–$15KOct 7, 201959dDec 5PDF
Susie LeeD-NVNV03CRLCharles River Laboratories International, Inc. · JointBuy$1K–$15KAug 29, 201932dSep 30PDF
Lamar SmithR-TXTX21CRLCharles River Laboratories International, Inc.Sell$1K–$15KSep 26, 201813dOct 9PDF
Thomas MacArthurR-NJNJ03CRLCharles River Laboratories International, Inc. · JointBuy$1K–$15KSep 19, 201817dOct 6PDF
Thomas MacArthurR-NJNJ03CRLCharles River Laboratories International, Inc. · JointBuy$1K–$15KSep 13, 201823dOct 6PDF
Thomas MacArthurR-NJNJ03CRLCharles River Laboratories International, Inc. · JointBuy$1K–$15KSep 12, 201824dOct 6PDF
Thomas MacArthurR-NJNJ03CRLCharles River Laboratories International, Inc. · JointBuy$1K–$15KSep 11, 201825dOct 6PDF
Lamar SmithR-TXTX21CRLCharles River Laboratories International, Inc.Sell$1K–$15KJul 26, 201813dAug 8PDF
Lamar SmithR-TXTX21CRLCharles River Laboratories International, Inc.Buy$1K–$15KFeb 13, 201822dMar 7PDF

Members who traded CRL

MemberTradesBuysSellsLast tradedLatest report
Thomas MacArthurR-NJNJ03440Sep 19, 2018Oct 6, 2018
Susie LeeD-NVNV03312Oct 8, 2019Dec 5, 2019
Lamar SmithR-TXTX21312Sep 26, 2018Oct 9, 2018
Donald TrumpPresident211Apr 27, 2026Jul 1, 2026
Jefferson ShreveR-ININ06211May 12, 2025Jun 22, 2025
Rob BresnahanR-PAPA08211May 15, 2025May 31, 2025
Lois FrankelD-FLFL22211Sep 8, 2023Oct 10, 2023
Zoe LofgrenD-CACA19211Aug 25, 2022Sep 13, 2022
Lori Chavez-DeRemerSecretary, Department of Labor101Apr 28, 2025Sep 9, 2025
Julie JohnsonD-TXTX32110Jan 15, 2025Feb 12, 2025
Eric LanderDirector, Office of Science and Technology Policy101Jun 10, 2021Sep 8, 2021
Donna ShalalaD-FLFL27101Jun 24, 2019Apr 27, 2020

Source

Each trade is a line of a periodic transaction report filed under the STOCK Act, read from the report itself and linked to it. Three offices publish them, and all three are read here every hour: the House Clerk for representatives, the Senate Office of Public Records for senators, and the Office of Government Ethics for the President, the Vice President and Senate-confirmed officials (OGE Form 278-T). OGE links some officials’ reports and releases the rest on request; only linked reports are here.

The Act requires a report within 45 days of the trade; the lag counts the days from the trade to the day the report became public. Reports give each amount as a range. Amendments are marked and not counted as late; trades a later report withdrew are left out. The President’s reports and some House reports are scans of paper forms: a scanned value that does not read with certainty is shown as not read, never guessed, and the report is one click away. “Since” is the stock’s move from the trade date’s close to the latest daily close.

The same trades are in the OptimistFi MCP server’s get_congress_trades tool, by filer or by stock, for each chamber: connect it. Every House trade is free to download as CSV or JSON, and every trade here can be followed by RSS: the data.

ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.